Showing results (51-60 of 322) with videos related to
Sort By:
Pageof 33
Blood Research|July 13, 2017
Clinical characteristics, treatment, and outcome of primary rectal lymphoma: a single center experience of 16 patientsJae Ho Jeong, Shin Kim, Jeong Eun Kim, et al.Cancer Research and Treatment|October 28, 2014
Primary histiocytic sarcoma of the central nervous systemHoonsub So, Sun A Kim, Dok Hyun Yoon, et al.The Korean Journal of Internal Medicine|June 23, 2009
Clinicopathologic characteristics of T-cell non-Hodgkin's lymphoma: a single institution experienceOck Bae Ko, Dae Ho Lee, Sang We Kim, et al.Annals of Hematology|November 9, 2012
Blastic plasmacytoid dendritic cell neoplasm: a single-center experienceHo Jung An, Dok Hyun Yoon, Shin Kim, et al.Clinical Lymphoma, Myeloma & Leukemia|December 31, 2011
Lower dose dexamethasone/thalidomide and zoledronic acid every 3 weeks in previously untreated multiple myelomaGerrard Teoh, Yuming Chen, Kihyun Kim, et al.Annals of Hematology|July 9, 2013
Changing trend of Epstein-Barr virus association in Hodgkin lymphoma in the Republic of KoreaYoung Wha Koh, Hyo Jeong Kang, Dok Hyun Yoon, et al.The Korean Journal of Internal Medicine|October 18, 2007
Mediastinal single nodal relapse of a nasal NK/T cell lymphomaKyoung Hoon Rhee, Seok Chan Hong, Jeong Min An, et al.Leukemia & Lymphoma|June 11, 2014
Prognostic impact of β₂-microglobulin in patients with non-gastric mucosa-associated lymphoid tissue lymphomaChanghoon Yoo, Dok Hyun Yoon, Shinkyo Yoon, et al.Blood Research|April 12, 2014
Primary mediastinal large B-cell lymphoma: a single-center experience in KoreaHeui June Ahn, Dok-Hyun Yoon, Shin Kim, et al.Journal of Korean Medical Science|August 8, 2006
Comparison of serum beta 2-microglobulin and 24 hour urinary creatinine clearance as a prognostic factor in multiple myelomaJae-Pil Yun, Cheolwon Suh, Eunkyoung Lee, et al.Pageof 33